Okyo Pharma Limited (OKYO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Operating Expenses | 7,092 | 15,750 | 13,187 | 6,218 | 4,133 |
| Operating Income | -7,092 | -15,750 | -13,187 | -6,218 | -4,133 |
| Interest Expense | 870 | 1,053 | 97 | 0 | 1 |
| Other Income | -8 | 0 | 0 | 0 | -12 |
| Pre-tax Income | -7,970 | -16,803 | -13,284 | -6,218 | -4,146 |
| Income Tax | -3,264 | 22 | -12 | -787 | -26 |
| Net Income Continuous | -4,706 | -16,825 | -13,272 | -5,431 | -4,120 |
| Net Income | $-4,706 | $-16,825 | $-13,272 | $-5,431 | $-4,120 |
| EPS Basic Total Ops | N/A | N/A | N/A | -0.01 | 0.00 |
| EPS Basic Continuous Ops | N/A | N/A | N/A | -0.01 | 0.00 |
| EPS Diluted Total Ops | N/A | N/A | N/A | -0.01 | 0.00 |
| EPS Diluted Continuous Ops | N/A | N/A | N/A | -0.01 | 0.00 |
| EBITDA(a) | $-7,097 | $-15,746 | $-13,183 | $-6,215 | $-4,131 |